Ipsen's Peter Koetsier says Medicines Australia must take up the invitation of PBAC chair Professor Andrew Wilson to engage in a review and potential changes to National Medicines Policy. …
Ipsen's Peter Koetsier: An opportunity too good to miss
September 17, 2017 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Auditor General finds the administration of the PBS 'partly effective'
December 17, 2024 - - Latest News -
Call for action as pneumococcal outbreak hits 20 year high
December 17, 2024 - - Latest News -
Australian Medtech Manufacturing Alliance strengthens with new steering group members
December 16, 2024 - - Australian Biotech -
AusBiotech and BioNSW deepen collaboration with new MOU
December 16, 2024 - - Australian Biotech -
PYC nominates fourth clinical drug candidate in Phelan-McDermid program
December 16, 2024 - - Australian Biotech -
Immutep and Monash announce first publication detailing how human LAG-3 Binds to MHC Class II
December 16, 2024 - - Australian Biotech -
'They intended to launch a product on the market when that was not their intention'
December 16, 2024 - - BioPharma